Shenzhen - Delayed Quote CNY

Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)

33.86

+0.56

+(1.68%)

At close: 3:04:18 PM GMT+8

Key Events

Loading Chart for 002422.SZ

Previous Close 33.30
Open 34.05
Bid 33.84 x --
Ask 33.85 x --
Day's Range 33.50 - 34.19
52 Week Range 25.72 - 38.08
Volume 16,125,600
Avg. Volume 20,607,202
Market Cap (intraday) 54.11B
Beta (5Y Monthly) -0.02
PE Ratio (TTM) 21.71
EPS (TTM) 1.56
Earnings Date Apr 30, 2025
Forward Dividend & Yield 0.52 (1.56%)
Ex-Dividend Date Oct 23, 2024
1y Target Est 43.08

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.

21,864

Full Time Employees

December 31

Fiscal Year Ends

Sector

Drug Manufacturers - General

Industry

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002422.SZ

13.13%

SSE Composite Index (000001.SS)

0.69%

1-Year Return

002422.SZ

0.46%

SSE Composite Index (000001.SS)

7.21%

3-Year Return

002422.SZ

99.51%

SSE Composite Index (000001.SS)

9.42%

5-Year Return

002422.SZ

83.27%

SSE Composite Index (000001.SS)

16.45%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Sichuan Kelun Pharmaceutical Co., Ltd.

33.86

+1.68%

Mkt Cap CNY 54.11B

Industry Drug Manufacturers—General

108.95

+0.23%

Mkt Cap 217.129B

Industry Drug Manufacturers—General

Bristol-Myers Squibb Company

48.18

+3.72%

Mkt Cap 98.05B

Industry Drug Manufacturers—General

Merck & Co., Inc.

80.43

+5.87%

Mkt Cap 201.962B

Industry Drug Manufacturers—General

23.09

+3.64%

Mkt Cap 131.275B

Industry Drug Manufacturers—General

Valuation Measures

    Annual 

As of 5/12/2025

Market Cap

53.22B
Enterprise Value

51.49B
Trailing P/E

21.35
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

2.65
Price/Book (mrq)

2.30
Enterprise Value/Revenue

2.58
Enterprise Value/EBITDA

14.45

Financial Highlights

Profitability and Income Statement

Profit Margin

12.48%
Return on Assets (ttm)

5.30%
Return on Equity (ttm)

10.27%
Revenue (ttm)

19.98B
Net Income Avi to Common (ttm)

2.49B
Diluted EPS (ttm)

1.56

Balance Sheet and Cash Flow

Total Cash (mrq)

6.32B
Total Debt/Equity (mrq)

16.77%
Levered Free Cash Flow (ttm)

1.37B

000963.SZ Huadong Medicine Co., Ltd

39.01

+3.58%

000538.SZ Yunnan Baiyao Group Co.,Ltd

57.06

-0.02%

000423.SZ Dong-E-E-Jiao Co.,Ltd.

55.51

-0.23%

002294.SZ Shenzhen Salubris Pharmaceuticals Co., Ltd.

38.88

+0.86%

002007.SZ Hualan Biological Engineering Inc.

16.42

+0.37%

002001.SZ Zhejiang NHU Company Ltd.

22.45

+1.86%

000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

42.17

+0.67%

002399.SZ Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

11.08

+0.45%

000876.SZ New Hope Liuhe Co.,Ltd.

9.71

+0.52%

002304.SZ Jiangsu Yanghe Distillery Co., Ltd.

69.22

+0.33%

000783.SZ Changjiang Securities Company Limited

6.61

-0.15%

300003.SZ Lepu Medical Technology (Beijing) Co., Ltd.

11.43

+0.62%

002142.SZ Bank of Ningbo Co., Ltd.

25.48

+0.63%

002465.SZ Guangzhou Haige Communications Group Incorporated Company

10.94

-2.76%

000728.SZ Guoyuan Securities Company Limited

7.64

+0.13%

000513.SZ Livzon Pharmaceutical Group Inc.

35.10

+0.03%